EMG
BIO icon

Ellington Management Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Ellington Management Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-700
Closed -$219K – 599
2019
Q2 		$219K Buy
+700
New +$210K 0.04% 458
2017
Q3 		– Sell
-2,100
Closed -$475K – 643
2017
Q2 		$475K Buy
+2,100
New +$458K 0.07% 254
2016
Q1 		– Sell
-2,900
Closed -$402K – 507
2015
Q4 		$402K Buy
+2,900
New +$402K 0.14% 195
2014
Q2 		– Sell
-3,700
Closed -$474K – 455
2014
Q1 		$474K Buy
+3,700
New +$474K 0.14% 228

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return